Hillan Kenneth J.
Chief Therapeutics Officer at ME; Officer, Director at Achaogen Inc; Director at Relypsa Inc
- Sold, on record
- $296k
- Dollars the filings state
- Form 4 sales
- 9
- Latest Aug 24, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- ME23andMe Holding Co.Chief Therapeutics Officer
- Achaogen IncOfficer, Director
- Relypsa IncDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Achaogen Inc17,863 shares
- ME8,753 shares
- Relypsa Inc1,013 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Relypsa IncUnusualJun 7 2016
Sold 1,013 shares at $19.31 ($20k)
Hillan Kenneth J., Director
Sold 45% of holdings ($43k position)1,237 shares leftFirst sale on recordFiling
- 2 Form 4 sale Achaogen IncPlan not statedJan 26 +233 days
Sold 1,431 shares at $16.78 ($24k)
Hillan Kenneth J., Chief Executive Officer
Sold 2.2% of holdings ($1.1M position)63,197 shares leftFiling
- 3 Form 4 sale Achaogen IncPlan not statedFeb 21 +26 days
Sold 1,696 shares at $22.76 ($39k)
Hillan Kenneth J., Chief Executive Officer
Sold 2.7% of holdings ($1.4M position)61,501 shares leftFiling
- 4 Form 4 sale Achaogen IncPlan not statedMar 14 +21 days
Sold 3,079 shares at $26.58 ($82k)
Hillan Kenneth J., Chief Executive Officer
Sold 3% of holdings ($2.7M position)98,422 shares left1.8x usual sizeFiling
- 5 Form 4 sale Achaogen IncPlan not statedFeb 21 +344 days
Sold 4,606 shares at $10.67 ($49k)
Hillan Kenneth J., Officer, Director
Sold 4.5% of holdings ($1.1M position)97,886 shares left1.9x usual sizeFiling
- 6 Form 4 sale Achaogen IncPlan not statedMar 13 +20 days
Sold 2,735 shares at $11.74 ($32k)
Hillan Kenneth J., Officer, Director
Sold 2.8% of holdings ($1.1M position)95,151 shares left0.9x usual sizeFiling
- 7 Form 4 sale Achaogen IncPlan not statedJun 26 +105 days
Sold 744 shares at $9.59 ($7k)
Hillan Kenneth J., Officer, Director
Sold 0.6% of holdings ($1.1M position)115,401 shares left0.3x usual sizeFiling
- 8 Form 4 sale MEPlan not statedAug 24 +1520 days
Sold 8,753 shares at $3.64 ($32k)
Hillan Kenneth J., Chief Therapeutics Officer
Sold 4.3% of holdings ($746k position)196,083 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2022 | ME | Chief Therapeutics Officer | Form 4 sale | 8,753 | $32k | 4.3% | Plan not stated | SEC |
| Jun 26, 2018 | Achaogen Inc | Officer, Director | Form 4 sale | 744 | $7k | 0.6% | Plan not stated | SEC |
| Mar 13, 2018 | Achaogen Inc | Officer, Director | Form 4 sale | 2,735 | $32k | 2.8% | Plan not stated | SEC |
| Feb 21, 2018 | Achaogen Inc | Officer, Director | Form 4 sale | 4,606 | $49k | 4.5% | Plan not stated | SEC |
| Mar 14, 2017 | Achaogen Inc | Chief Executive Officer | Form 4 sale | 3,079 | $82k | 3.0% | Plan not stated | SEC |
| Feb 21, 2017 | Achaogen Inc | Chief Executive Officer | Form 4 sale | 1,696 | $39k | 2.7% | Plan not stated | SEC |
| Jan 26, 2017 | Achaogen Inc | Chief Executive Officer | Form 4 sale | 1,431 | $24k | 2.2% | Plan not stated | SEC |
| Jun 7, 2016 | Relypsa Inc | Director | Form 4 sale | 1,013 | $20k | 45.0% | Unusual | SEC |
| Mar 17, 2016 | Achaogen Inc | Chief Executive Officer | Form 4 sale | 3,572 | $12k | 5.5% | Plan not stated | SEC |